# A Study of RBI-4000 in Healthy Participants

> **NCT06048770** · PHASE1 · TERMINATED · sponsor: **Replicate Bioscience** · enrollment: 89 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** RBI-4000
- **BIOLOGICAL:** RabAvert

## Key facts

- **NCT ID:** NCT06048770
- **Lead sponsor:** Replicate Bioscience
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-09-01
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 89 (ACTUAL)
- **Why stopped:** Strategic business decision (not related to safety, efficacy, or quality)
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06048770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06048770, "A Study of RBI-4000 in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06048770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*